Automated breast density measurement predicts breast cancer risk in young women Automated breast density measurement is certainly predictive of breast cancer risk in more youthful women, and that risk could be linked to the rate of which breast density changes in a few women because they age, according to analyze being presented today at the annual achieving of the Radiological Society of THE UNITED STATES . Breasts density, as dependant on mammography, has already been known to become a independent and strong risk aspect for breast cancer. The American Cancer Culture considers females with incredibly dense breasts to end up being at moderately increased threat of malignancy and recommends they talk to their doctors about adding magnetic resonance imaging screening with their yearly mammograms read more .

AutoGenomics granted FDA 510 clearance for INFINITI CYP2C19 Assay AutoGenomics, a innovator in providing automated, molecular tests solutions announced today that it all offers received 510 clearance from the U.S. The requirement of this genetic check offers been implicated in literature right now for quite some time. That is a significant milestone in the period of personalized medicine. Many of our clients are awaiting such clearance to put into action testing within their practice. He said further, we continue to broaden our portfolio of FDA cleared items. Resource AutoGenomics.